NCT01995240View on ClinicalTrials.gov

Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Pancreatic Cancer
Interventions
DRUG

Gadobutrol

0.1 ml/kg Gadovist is administered at 5 ml/s followed by a 15 ml saline flush

Trial Locations (1)

1105AZ

Academic Medical Center, Amsterdam

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT01995240 - Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study | Biotech Hunter | Biotech Hunter